SCHEMBL2209573

SCHEMBL2209573

COC(=O)c1nc2n(c(=O)c1O)CCOCC2N(C)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HSP90AA1 P07900 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
RNASEH1 O60930 1/20 0.39
CYP2C9 P11712 2/20 0.37
KCNH2 Q12809 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPK1 P28482 1/20 0.37
PIK3CA P42336 2/20 0.36
PIK3CB P42338 1/20 0.36
NAPEPLD Q6IQ20 4/20 0.36
ERCC1 P07992 1/20 0.34
FEN1 P39748 1/20 0.34
ERCC4 Q92889 1/20 0.34
HPGD P15428 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1751097 0.85 KCNH2 (0.47) ALDH1A1HSP90AA1MAPTHTTSMN1; SMN2
SCHEMBL2202249 0.84 ALDH1A1 (0.43) ALDH1A1HSP90AA1MAPTHTTSMN1; SMN2
SCHEMBL2206742 0.83 ALDH1A1 (0.42) ALDH1A1HSP90AA1MAPTHTTSMN1; SMN2
SCHEMBL2208599 0.80 JAK2 (0.49) ALDH1A1HSP90AA1MAPTHTTSMN1; SMN2
SCHEMBL13672439 0.76 ALDH1A1 (0.38) ALDH1A1MAPTSMN1; SMN2KDM4EMAPK1
SCHEMBL1379533 0.70 KCNH2 (0.72) ALDH1A1MAPTSMN1; SMN2CYP2C9KCNH2
SCHEMBL2205410 0.67 CYP2C9 (0.77) ALDH1A1MAPTSMN1; SMN2CYP2C9KCNH2
SCHEMBL12222752 0.67 ALDH1A1 (0.39) ALDH1A1MAPTSMN1; SMN2KDM4EMAPK1
Trifluoroacetic Acid SCHEMBL1751641 0.67 KCNH2 (0.43) RNASEH1CYP2C9KCNH2KDM4EERCC1
SCHEMBL2206374 0.66 ALDH1A1 (0.40) ALDH1A1HSP90AA1MAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110257162-A1 HIV INTEGRASE INHIBITORS SUMMA VINCENZO 2011-10-20 US disclosed
US-7981879-B2 HIV integrase inhibitors Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. (IT) 2011-07-19 US disclosed
US-20090253681-A1 HIV Integrase Inhibitors MSD ITALIA S.R.L. (IT) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257162-A1 HIV INTEGRASE INHIBITORS REV1, CDK9, INTS9 ALDH1A1 4016/4885HSP90AA1 3958/4885MAPT 2670/4885
US-20090253681-A1 HIV Integrase Inhibitors REV1, INTS9, H1-10 ALDH1A1 4120/4885HSP90AA1 2992/4885MAPT 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.